![Medicinal Chemistry Strategies for the Development of Bruton's Tyrosine Kinase Inhibitors against Resistance | Journal of Medicinal Chemistry Medicinal Chemistry Strategies for the Development of Bruton's Tyrosine Kinase Inhibitors against Resistance | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00030/asset/images/large/jm2c00030_0014.jpeg)
Medicinal Chemistry Strategies for the Development of Bruton's Tyrosine Kinase Inhibitors against Resistance | Journal of Medicinal Chemistry
![Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes | American Journal of Physiology-Renal Physiology Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes | American Journal of Physiology-Renal Physiology](https://journals.physiology.org/cms/10.1152/ajprenal.00097.2021/asset/images/medium/f-00097-2021r01.png)
Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes | American Journal of Physiology-Renal Physiology
![PDF) Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways PDF) Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways](https://www.researchgate.net/publication/302058301/figure/fig5/AS:362150620090374@1463354844975/Sorafenib-downregulates-the-Raf-MEK-ERK-signaling-pathway-and-concurrent-treatment-with_Q320.jpg)
PDF) Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways
![An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis | Cell Death & Disease An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-022-04692-1/MediaObjects/41419_2022_4692_Fig1_HTML.png)
An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis | Cell Death & Disease
![Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone - ScienceDirect Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009279715002252-fx1.jpg)
Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone - ScienceDirect
![Cancers | Free Full-Text | How Prostate Cancer Cells Use Strategy Instead of Brute Force to Achieve Metastasis Cancers | Free Full-Text | How Prostate Cancer Cells Use Strategy Instead of Brute Force to Achieve Metastasis](https://www.mdpi.com/cancers/cancers-11-01928/article_deploy/html/images/cancers-11-01928-g001.png)